title: C5b-9 regulates peritubular myofibroblast accumulation in experimental focal segmental glomerulosclerosis.
abstract: BACKGROUND
  In human focal segmental glomerulosclerosis (FSGS), the tubulointerstitial deposition of the complement (C5b-9) membrane attack complex is correlated with interstitial myofibroblast accumulation and proteinuria. Here, we hypothesized that C5b-9 formation regulates renal myofibroblast accumulation in Adriamycin nephropathy.
  
  
  METHODS
  Adriamycin nephropathy was induced in complement C6-sufficient (C6+) and C6-deficient (C6-) piebold viral glaxo (PVG) rats. Groups of animals (N= 7 to 8 each) were examined on days 21 and 42. A group of C6+ animals, injected with vehicle, served as the control group.
  
  
  RESULTS
  C6+ and C6- rats with Adriamycin nephropathy had equivalent proteinuria. C5b-9 deposition was increased and present on the apical surface of proximal tubular epithelial cells (day 21 and 42) and peritubular region (day 42 only) in C6+ rats with Adriamycin nephropathy, and absent in C6- rats. Peritubular myofibroblast accumulation increased in a time-dependent manner in C6+ proteinuric rats (control 1.2 +/- 0.4; Adriamycin nephropathy day 21 11.0 +/- 0.7; Adriamycin nephropathy day 42 19.8 +/- 1.7 cells per high power field). In C6- rats this increase was blunted by 87% and 56% on days 21 and 42, respectively (P < 0.01), and was associated with reduced interstitial extracellular matrix (ECM) deposition. Tubulointerstitial injury, tubular vimentin and interstitial monocyte accumulation were also reduced in C6- rats with Adriamycin nephropathy on day 21, but not at day 42. In contrast, the increase in periglomerular myofibroblast accumulation and glomerulosclerosis in Adriamycin nephropathy were not altered by C6 deficiency.
  
  
  CONCLUSIONS
  These data suggest that glomerular ultrafiltration of complement components and the intratubular formation of C5b-9 is a specific promotor of peritubular myofibroblast accumulation in FSGS.
authors.affiliation: Division of Nephrology, University of Washington Medical Center, Seattle, Washington, USA. g.rangan@wmi.usyd.edu.au
authors.forename: Gopala K
authors.initials: GK
authors.lastname: Rangan
authors.forename: Jeffrey W
authors.initials: JW
authors.lastname: Pippin
authors.forename: William G
authors.initials: WG
authors.lastname: Couser
mesh_terms: D000818:Animals; D002455:Cell Division; D003183:Complement C6 / Q000172:deficiency / Q000378:metabolism; D015938:Complement Membrane Attack Complex / Q000378:metabolism*; D004195:Disease Models, Animal; D004317:Doxorubicin; D005109:Extracellular Matrix / Q000378:metabolism; D005347:Fibroblasts / Q000473:pathology*; D005923:Glomerulosclerosis, Focal Segmental / Q000378:metabolism* / Q000473:pathology*; D007668:Kidney / Q000473:pathology; D007674:Kidney Diseases / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology; D007684:Kidney Tubules / Q000473:pathology*; D008297:Male; D032389:Myocytes, Smooth Muscle / Q000473:pathology*; D009929:Organ Size; D051381:Rats; D011919:Rats, Inbred Strains; D013997:Time Factors
chemical_list: D003183:Complement C6; D015938:Complement Membrane Attack Complex; D004317:Doxorubicin